Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radium Bromatum for Radiodermatitis Prevention in Breast Cancer
NCT03753776Phase 3Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Jul 2019
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of radium bromide in radiodermatitis, sponsored by CHU Saint-Etienne. Started Jul 2019; status: completed.
02
Drugs
radium bromide
03
Conditions
radiodermatitis
Beyond the preview
Go deeper on NCT03753776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03753776.